Medical Articles 4/8
Posted by rob on April 8, 2009 under Uncategorized | 
Be the First to Comment
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.